This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

Troutman Pepper Locke

| less than a minute read

The Skinny Labeling Saga Continues

Overview of the Supreme Court’s review of skinny labeling in Amarin Inc. v. Hikma Pharm. USA, Inc., and its implications for generic drug makers, marketing, and inducement liability.